News Conference News NY Valves 2025 Prompt TAVI Benefits Asymptomatic AS Patients Regardless of Guideline Indication Todd Neale June 27, 2025
News Conference News NY Valves 2024 Good 3-Year Outcomes With Aortic Valve-in-Valve Replacement for Failed SAVR Michael O'Riordan June 11, 2024
Presentation NY Valves 2024 Trans-Atrial Implantation of Sapien 3 Valve for Severe MS in a High Risk Patient Using Right Thoracotomy Approach With Fibrillatory Arrest Presenter: Gianfranco Bittar Carlini June 07, 2024
Presentation NY Valves 2024 Partner Valves: Role of a Prospective Device Selection Strategy Using Acurate and SAPIEN 3 as Complementary Devices in Transcatheter Aortic Valve Replacement Presenter: Jonathan Michel June 07, 2024
Presentation NY Valves 2024 EFS of the Edwards SAPIEN 3 THV System With the Edwards Caval Pre-Stent for the Treatment of Reverse Caval Flow in Patients With Severe TR Presenter: Brian P. O'Neill June 06, 2024
Presentation NY Valves 2024 Suitability of Mitral Annuloplasty Rings for a Valve-in-Ring Procedure With SAPIEN 3 Presenter: Syed Zaid June 06, 2024
News Conference News NY Valves 2024 Reassuring 5-Year Outcomes for Sapien-Treated TAVI Patients With Small Annuli Michael O'Riordan June 05, 2024